Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease
- 14 June 2002
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 328 (1) , 9-12
- https://doi.org/10.1016/s0304-3940(02)00443-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Genetic variation in α1-antichymotrypsin and its association with Alzheimer’s diseaseHuman Genetics, 2002
- A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's DiseaseNeurobiology of Disease, 2001
- Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse ModelNeurobiology of Disease, 2000
- Plasma 24S-hydroxycholesterolNeuroReport, 2000
- Apolipoprotein E Genetic Variation and Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 1999
- A4POE*4-associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphismNature Genetics, 1995
- The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, ColoradoAtherosclerosis, 1995
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Regional location of α1-antichymotrypsin and α1-antitrypsin genes on human chromosome 14Somatic Cell and Molecular Genetics, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984